Clinical Trial 41898

Winter Haven, FL 33880


To evaluate the efficacy, safety and tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the acute treatment of a migraine.

Qualified Participants Must:

• Be at least 18 years of age
• Experience at least 2 migraines per month over the last 6 months

Qualified Participants May Receive:

- Study related procedures such as blood work and ECG

- Compensation for time and travel expenses

- Physical performed by a board certified physician

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.